Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study.


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
25 08 2021
Historique:
pubmed: 29 7 2021
medline: 13 1 2022
entrez: 28 7 2021
Statut: ppublish

Résumé

The hemagglutination inhibition (HAI) assay is an established technique for assessing influenza immunity, through measurement of antihemagglutinin antibodies. Improved reproducibility of this assay is required to provide meaningful data across different testing laboratories. This study assessed the impact of harmonizing the HAI assay protocol/reagents and using standards on interlaboratory variability. Human pre- and postvaccination sera from individuals (

Identifiants

pubmed: 34319129
doi: 10.1128/mSphere.00567-21
pmc: PMC8530177
doi:

Substances chimiques

Antibodies, Viral 0
Influenza Vaccines 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0056721

Références

J Gen Virol. 2017 Jun;98(6):1274-1281
pubmed: 28612701
Vaccine. 2007 May 16;25(20):4056-63
pubmed: 17412461
Clin Vaccine Immunol. 2016 Jan 27;23(3):236-42
pubmed: 26818953
J Immunol. 2019 Jan 15;202(2):335-340
pubmed: 30617114
J Hyg (Lond). 1972 Dec;70(4):767-77
pubmed: 4509641
Influenza Other Respir Viruses. 2013 Mar;7(2):211-24
pubmed: 22548725
Vaccine. 2012 Jan 5;30(2):210-7
pubmed: 22100887
Vaccine. 2012 Jun 8;30(27):4113-22
pubmed: 22446639
Vaccines (Basel). 2018 May 21;6(2):
pubmed: 29883414
Vaccines (Basel). 2014 Oct 13;2(4):707-34
pubmed: 26344888
Vaccine. 1994 Feb;12(2):167-74
pubmed: 8147099
J Clin Microbiol. 1981 Jan;13(1):54-7
pubmed: 7462419
Emerg Infect Dis. 2009 Aug;15(8):1252-9
pubmed: 19751587
Trends Immunol. 2018 Jan;39(1):70-79
pubmed: 28867526

Auteurs

Joanna Waldock (J)

National Institute for Biological Standards and Control, Potters Bar, United Kingdom.

Lingyi Zheng (L)

Sanofi Pasteur, Swiftwater, Pennsylvania, USA.

Edmond J Remarque (EJ)

Biomedical Primate Research Centre, Rijswijk, The Netherlands.

Alexandre Civet (A)

Quinten, Paris, France.

Branda Hu (B)

Sanofi Pasteur, Swiftwater, Pennsylvania, USA.

Sarah Lartey Jalloh (SL)

Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway.

Rebecca Jane Cox (RJ)

Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway.

Sammy Ho (S)

Public Health Englandgrid.271308.f, Colindale, United Kingdom.

Katja Hoschler (K)

Public Health Englandgrid.271308.f, Colindale, United Kingdom.

Thierry Ollinger (T)

GSK, Wavre, Belgium.

Claudia Maria Trombetta (CM)

University of Siena, Department of Molecular and Developmental Medicine, Siena, Italy.

Othmar G Engelhardt (OG)

National Institute for Biological Standards and Control, Potters Bar, United Kingdom.

Catherine Caillet (C)

Sanofi Pasteur, Swiftwater, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH